Journal of Addiction Research & Therapy
黑料网
Like us on:
organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
黑料网 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Citations : 4859
Indexed In
- CAS Source Index (CASSI)
- Index Copernicus
- Google Scholar
- Sherpa Romeo
- Open J Gate
- Genamics JournalSeek
- Academic Keys
- JournalTOCs
- SafetyLit
- China National Knowledge Infrastructure (CNKI)
- Electronic Journals Library
- RefSeek
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- SWB online catalog
- Virtual Library of Biology (vifabio)
- Publons
- Geneva Foundation for Medical Education and Research
- Euro Pub
- ICMJE
Useful Links
Recommended Journals
Related Subjects
Share This Page
Journal of Addiction Research & Therapy : Citations & Metrics Report
Articles published in Journal of Addiction Research & Therapy have been cited by esteemed scholars and scientists all around the world. Journal of Addiction Research & Therapy has got h-index 34, which means every article in Journal of Addiction Research & Therapy has got 34 average citations.
Following are the list of articles that have cited the articles published in Journal of Addiction Research & Therapy.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
Total published articles |
88 | 88 | 61 | 59 | 24 | 28 | 24 | 59 | 48 |
Research, Review articles and Editorials |
20 | 68 | 49 | 7 | 8 | 18 | 0 | 0 | 0 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
68 | 0 | 1 | 15 | 3 | 1 | 0 | 0 | 0 |
Conference proceedings |
0 | 11 | 5 | 0 | 0 | 0 | 85 | 56 | 105 |
Citations received as per Google Scholar, other indexing platforms and portals |
90 | 168 | 573 | 612 | 590 | 545 | 567 | 473 | 440 |
| Journal total citations count | 4859 |
| Journal impact factor | 9.79 |
| Journal 5 years impact factor | 14.65 |
| Journal cite score | 13.41 |
| Journal h-index | 34 |
| Journal h-index since 2019 | 26 |
 |
Twining RC, Tuscher JJ, Doncheck EM, Frick KM, Mueller D. Proof Only. Learning & Memory.;120(20):1-8. |
| | | |
|
Becker JB (2016) Sex differences in addiction. Dialogues in clinical neuroscience 18: 395. |
| | | |
|
Becker JB, McClellan ML, Reed BG (2017) Sex differences, gender and addiction. Journal of neuroscience research 2: 136-147. |
| | | |
|
Richard JE, Anderberg RH, López-Ferreras L, Olandersson K, Skibicka KP (2016) Sex and estrogens alter the action of glucagon-like peptide-1 on reward. Biology of sex differences 7: 6. |
| | | |
|
Twining RC, Tuscher JJ, Doncheck EM, Frick KM, Mueller D (2013) 17β-Estradiol is necessary for extinction of cocaine seeking in female rats. Learning & memory 20: 300-306. |
| | | |
|
Cruz G, Riquelme R, Espinosa P, Jara P, Dagnino-Subiabre A, Renard GM, Sotomayor-Zarate R (2014) Neonatal exposure to estradiol valerate increases dopamine content in nigrostriatal pathway during adulthood in the rat. Hormone and Metabolic Research 46: 322-327. |
| | | |
|
Cox KH, Bonthuis PJ, Rissman EF (2014) Mouse model systems to study sex chromosome genes and behavior: relevance to humans. Frontiers in neuroendocrinology 35: 405-419. |
| | | |
|
Perry AN, Westenbroek C, Becker JB (2013) The development of a preference for cocaine over food identifies individual rats with addiction-like behaviors. PloS one 8: e79465. |
| | | |
|
dos Reis AS, em Álcool UD. Revisão da Literatura Sobre a Associação entre Tabagismo e Esquizofrenia. |
| | | |
|
Almadana Pacheco V. Niveles de ansiedad y depresión en los fumadores que acuden a una consulta de deshabituación tabáquica y factores relacionados. |
| | | |
|
García-Portilla MP, Bobes J (2016) Programas de cesación tabáquica para personas con esquizofrenia: una necesidad urgente no cubierta. Revista de Psiquiatría y Salud Mental 9: 181-184. |
| | | |
|
Roig Cutillas P, Pinet Ogué M, Ballbè Gibernau M, Nieva Rifá G, Mondon Vehils S, et al. Vareniclina en el tratamiento del tabaquismo: efi cacia y seguridad en población general, psiquiátrica y drogodependiente. |
| | | |
|
Kurita M, García-Bea A, González-Maeso J (2016) Novel Targets for Drug Treatment in Psychiatry. InThe Medical Basis of Psychiatry. Springer New York. |
| | | |
|
García-Portilla MP, Bobes J (2016) Smoking cessation programs for persons with schizophrenia: An urgent unmet need. Revista de psiquiatria y salud mental 9: 181. |
| | | |
|
Deepika M. Research and Reviews: Journal of Medical and Health Sciences. |
| | | |
|
Garcia-Portilla MP, Garcia-Alvarez L, Sarramea F, Galvan G, Diaz-Mesa E, et al. (2016) It is feasible and effective to help patients with severe mental disorders to quit smoking: An ecological pragmatic clinical trial with transdermal nicotine patches and varenicline. Schizophrenia research 176: 272-280. |
| | | |
|
Hughes JR (2016) Varenicline as a cause of suicidal outcomes. Nicotine & Tobacco Research 18: 2-9. |
| | | |
|
Roberts E, Eden Evins A, McNeill A, Robson D (2016) Efficacy and tolerability of pharmacotherapy for smoking cessation in adults with serious mental illness: a systematic review and network meta脙垄芒聜卢脗聬analysis. Addiction. |
| | | |
|
Kishi T, Iwata N (2015) Varenicline for smoking cessation in people with schizophrenia: systematic review and meta-analysis. European archives of psychiatry and clinical neuroscience 265: 259-268. |
| | | |
|
Anthenelli RM, Benowitz NL, West R, St Aubin L, McRae T, et al. (2016) Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial. The Lancet 387: 2507-2520. |
| | | |
